Results 151 to 160 of about 15,262,784 (310)

Perspective of Liberian surgical care providers on ethical issues in global surgical collaborations. [PDF]

PLoS One
Kruth M, Dieudonné L, Udwadia F, Binda C, Joos E, Joharifard S.   +5 more
europepmc   +1 more source

Spring 2018, International Educator, Table of Contents [PDF]

, 2018
UNH Global Education Center
core   +2 more sources

Empowering Developing Countries to Lead the Aid Partnership [PDF]

human development, aid, trade ...
Alison Johnson and Matthew Martin
core  

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Evaluation of the Feasibility of Erecting a Regional Wind Energy System within the East Bay of Rhode Island [PDF]

, 2009
Sustainable Global Energy, LLC
core   +1 more source

Poverty and Human Development in India: Getting Priorities Right [PDF]

human development, poverty ...
A.K. Shiva Kumar
core  

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Estimation of the global number of nicotine vapers in 2025. [PDF]

Glob Epidemiol
Jerzyński T, Mzhavanadze G, Stimson GV.
europepmc   +1 more source

Fall 2017, International Education Week Kicks Off on November 13 [PDF]

, 2017
UNH Global Education Center
core   +2 more sources

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source